Scott G Williams COSA 2015 ASM

Abstracts this author is presenting:

• Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate  cancer: ENZARAD (ANZUP 1303) — Posters1